Imatinib induces apoptosis in CLL lymphocytes with high expression of Par-4.
about
Concomitant imatinib and ibrutinib in a patient with chronic myelogenous leukemia and chronic lymphocytic leukemia.Par-4/THAP1 complex and Notch3 competitively regulated pre-mRNA splicing of CCAR1 and affected inversely the survival of T-cell acute lymphoblastic leukemia cellsTyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders.Lymphocytes from chronic lymphocytic leukaemia undergo ABL1-linked amoeboid motility and homotypic interaction as an early adaptive change to ex vivo culture.The tyrosine kinase inhibitor AMN107 (Nilotinib) exhibits off-target effects in lymphoblastic cell lines.Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia.
P2860
Imatinib induces apoptosis in CLL lymphocytes with high expression of Par-4.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Imatinib induces apoptosis in CLL lymphocytes with high expression of Par-4.
@en
Imatinib induces apoptosis in CLL lymphocytes with high expression of Par-4.
@nl
type
label
Imatinib induces apoptosis in CLL lymphocytes with high expression of Par-4.
@en
Imatinib induces apoptosis in CLL lymphocytes with high expression of Par-4.
@nl
prefLabel
Imatinib induces apoptosis in CLL lymphocytes with high expression of Par-4.
@en
Imatinib induces apoptosis in CLL lymphocytes with high expression of Par-4.
@nl
P2093
P2860
P356
P1433
P1476
Imatinib induces apoptosis in CLL lymphocytes with high expression of Par-4.
@en
P2093
P2860
P2888
P304
1103-5; author reply 1105-6; discussion 1106-7
P356
10.1038/SJ.LEU.2403739
P577
2005-06-01T00:00:00Z